Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 111Neoplasms 8Neoplasm Metastasis 6Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 4Arthralgia 4Advanced Breast Cancer 4Osteoporosis 2Multiple Endocrine Neoplasia Type 1 2Breast Neoplasms, Male 2Breast Cancer Metastatic 2Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Seizures 1Recurrence 1Quality of Life 1Patient Compliance 1Pain 1Ovarian Neoplasms 1Obesity 1Lethal Congenital Contracture Syndrome 2 1Joint Diseases 1Invasive Breast Cancer 1Hypogonadism 1Granulosa Cell Ovarian Cancer 1Fractures, Bone 1Erectile Dysfunction 1Epilepsy 1Bone Diseases, Metabolic 1Bone Density 1

Interventions

LY3295668 erbumine 2Everolimus 2ziprasidone 1enzalutamide 1clevidipine 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sirolimus 1Sevoflurane 1Sevelamer 1Saline Solution 1Rocuronium 1Propofol 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nitrous Oxide 1Nifedipine 1Nafcillin 1Molindone 1Midazolam 1Methylprednisolone 1Mass Screening 1Lurasidone Hydrochloride 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Epilepsy × Anastrozole × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡